About
Advanced Catheter Therapies ("ACT") is a commercialization stage medical device company with a targeted portfolio of technologies for the treatment of vascular disease. It is developing an innovative and highly proprietary vascular clearing and drug delivery system of catheters. Our lead device is the FDA cleared and patented Pressana Occlusion Perfusion Catheter or OPC. It is a universal targeted liquid drug delivery platform system. It is extremely versatile able to precisely deliver most any physician selected agents into the periphery with little to no systemic release of the agent.
Technologies
Outlook
Google Cloud Hosting
Wix
Mobile Friendly
Varnish
Remote
AI
Keywords
biotechnology
life sciences
vascular therapy
endovascular drug delivery system
local treatment chamber
catheter-based therapy
therapeutic agent infusion
post-angioplasty drug infusion
medical devices
vascular disease innovation
peripheral artery disease treatment
below the knee use
liquid therapy delivery
occlusion perfusion catheter
peripheral ischemia treatment
catheter technology
healthcare
revascularization support
vascular disease management
peripheral vessel therapy
peripheral vessel occlusion
peripheral arterial disease
liquid drug perfusion
cost-effective medical device
real-time pressure sensing
peripheral vascular treatment
interventional cardiology
peripheral artery intervention
vascular access device
vascular occlusion balloons
Company Information
-
Employees 4
-
Founded 2008
-
Annual Revenue $3800000
-
Total Funding $10880000
Location
25 E Main St, Chattanooga, Tennessee, United States, 37408
